Exxon's earnings success signals a potential industry-wide move towards production-focused strategies. Companies that enable higher output could see increased demand as this approach gains traction.
These firms provide the critical drilling services and advanced technologies that make increased oil and gas production possible. They're positioned at the heart of the industry's operational excellence drive.
Professional analysts selected these companies for their central role in supporting higher production output. They represent the specialised firms best positioned to benefit from increased capital spending in exploration and production.
Interpretation of the basket's market capitalisation and investor takeaways.
XOM: $480.51B
HAL: $21.52B
SLB: $50.08B
Exxon Mobil's recent earnings success demonstrates that increasing production can effectively counter falling oil prices. This strategy shift suggests the energy sector may prioritise operational excellence and higher output over price dependency, creating opportunities for companies that enable this approach.
This group focuses on oilfield services and equipment companies that provide the essential tools, technologies, and services needed for increased oil and gas production. These firms operate in a specialised sector that could see rising demand as producers adopt output-focused strategies.
These companies were handpicked by professional analysts for their central role in the oil and gas production value chain. They provide critical drilling services, advanced extraction technologies, and essential hardware that major producers need to ramp up output and maintain profitability.
Exxon Mobil's recent earnings showed that boosting production can overcome low oil prices, highlighting a key strategy for success. This creates an investment opportunity in the companies providing the essential equipment and services that make increased oil and gas output possible.
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Veröffentlicht am August 1
+6
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
Es dauert nur 60 Sekunden.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+37.79%
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 37.79 % zulegen.
11 von 16 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
